TrueMark Investments’s Prime Medicine PRME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
Sell
-85,183
Closed -$596K 221
2024
Q1
$596K Buy
85,183
+10,153
+14% +$71.1K 0.55% 49
2023
Q4
$665K Buy
+75,030
New +$665K 0.66% 48